Back to Journals » Infection and Drug Resistance » Volume 15

Knowledge and Attitude Towards Human Papillomavirus Vaccine and Associated Factors Among Mothers Who Have Eligible Daughters in Debre Markos Town, Northwest Ethiopia

Authors Sinshaw MT, Berhe S , Ayele SG

Received 4 December 2021

Accepted for publication 25 February 2022

Published 3 March 2022 Volume 2022:15 Pages 781—793

DOI https://doi.org/10.2147/IDR.S352440

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Héctor Mora-Montes



Melkam Tesfaye Sinshaw,1 Semarya Berhe,2 Siraye Genzeb Ayele2

1Debre Markos University, College of Health Sciences, Department of Midwifery, Debre Markos, Ethiopia; 2Addis Ababa University, College of Health Sciences, School of Nursing and Midwifery, Department of Midwifery, Addis Ababa, Ethiopia

Correspondence: Siraye Genzeb Ayele, Addis Ababa University, College of Health Sciences, School of Nursing and Midwifery, Department of Midwifery, P.O.Box. 1176, Addis Ababa, Ethiopia, Tel +251951070730, Email [email protected]

Purpose: This study aimed to assess knowledge and attitude towards the human papillomavirus vaccine and associated factors among mothers who have eligible daughters.
Methods: A community-based cross-sectional study with a total sample of 601 study participants was conducted in Debre Markos town from February to March 2021. The study participants were selected using a multistage sampling technique from mothers who have eligible daughters. The data was collected using an interview administration questionnaire. The data were entered into EPI data version 3.1 then, exported to SPSS version 25 for analysis. Variables with a p-value of < 0.25 in bivariate were a candidate for multivariate and those variables with a p-value of < 0.05 in multivariate binary logistic regression were considered as a statistically significant factor for knowledge and attitude of the HPV vaccine.
Results: A total of 601 study participants with a response rate of 100% were included in the study. Among participants in this study, 47.6% have good knowledge and 77.4% have a positive attitude towards the HPV vaccine. Knowledge of mothers about HPV vaccine was affected by having degree and above (adjusted odds ratio (AOR) =7.687; 95% CI=1.837– 32.168; p=0.005), did not hear about HPV vaccine (AOR=0.172; 95% CI=0.098– 0.302; P=0.000), and positive attitude towards HPV vaccine (AOR=2.959; 95% CI=1.580– 5.539; P=0.001). Attitude of mothers towards HPV vaccine was affected by did not hear about HPV vaccine (AOR=0.285; 95% CI=0.163– 0.499; P=000), and good knowledge about HPV vaccine (AOR=2.705; 95% CI=1.454– 5.035; 0.002).
Conclusion: Knowledge of mothers who have eligible daughters about HPV vaccine was low. Maternal educational level, hearing about the HPV vaccine, and attitude towards HPV vaccine were significantly associated predictors with knowledge towards HPV vaccine. However, the attitude was high and factors associated with attitudes towards the HPV vaccine were knowledge about the HPV vaccine and hearing about the HPV vaccine. An integrated work should be considered by Debre Markos town health office with other non-governmental organizations working on health and health-related issues to improve knowledge about the importance of HPV vaccine for mothers who have eligible daughters.

Keywords: knowledge, attitude, human papillomavirus vaccine, mothers, Ethiopia

Introduction

The human papillomaviruses (HPVs) are a big group of highly ubiquitous, small, non-enveloped double-stranded circular deoxyribonucleic acid viruses. Both women and men are rapidly exposed to it after the onset of sexual intercourse.1,2 Types 16 and 18 of HPVs are the most prevalent cause of cervical cancer (CC) and the non-oncogenic types of HPV 6 and 11 are identified as the major causes for 90% of genital warts.3 Above 560,000 new cases of CC and about 275,000 deaths are recorded each year, with more than 80% occurring in developing countries.4–6

Globally, in 2018, CC was the fourth most common cancer among women with 570,000 new cases and 311,000 deaths (7.5% of all female cancer deaths). It is also one of the leading causes of cancer deaths among women in low and middle-income countries (LMICs), where 83% of new cases and 85% of related deaths occur.7

In sub-Saharan Africa (SSA), 34.8 new cases of CC are detected and 22.5 die per 100,000 women annually. According to the Global, Cancer Incidence, Mortality, and Prevalence (GLOBOCAN) data of 2018 the incidence of CC is 563,847 new cases worldwide, of which 52,633 occur in Eastern Africa.8

In Ethiopia, CC orders the second most common type of cancer among women. Every year, 7095 women are identified with CC, and 4732 die from the disease.9 The human papillomavirus vaccine has the great potential to prevent HPV-related infections for millions of women and men worldwide.10

In Ethiopia, the bivalent HPV vaccine was launched on 3rd December 2018 for girls who are 14 years of age.11 The vaccine is currently being delivered primarily through a School-based approach to reach all 14 years girls.5 However, Social influence, lack of knowledge about cervical cancer and screening, lack of health education on HPV vaccine were barriers to successful HPV vaccination campaign in Ethiopia.12

At present-day even if we have a comparatively clear picture of HPV infection’s natural history, oncogenic properties, screening, and prevention algorithms, HPV infection rates continue to persist, particularly in developing countries, where CC occurrence and prevalence are still high. This is due to different reasons, which include low socioeconomic status, lack of population awareness, and inadequately implemented screening and vaccination programs.13

Parents have a significant role in the decision-making process regarding the HPV vaccination for their children. Mainly, mothers are the primary decision-makers for their daughters. Human papillomavirus vaccination was initially promoted as a vaccine protecting against a female disease, CC.14 Despite the free HPV immunization, acceptance of the vaccination program is not guaranteed as some of the parents are still against it due to various reasons. It has been shown that knowledge of the consequences of HPV infection is lacking and many have misconceptions about vaccination.3

Lack of parental awareness can result in vaccine refusal and as a result, adolescent girls have expressed their reluctance to vaccinate without parental consent. Parents of adolescent girls need to be aware of HPV, how it is transmitted, and the efficacy of the HPV vaccine in preventing CC.15 Though knowledge and attitude about HPV vaccination is an essential factor for the success of the vaccination program to prevent CC; most of the mothers did not want HPV vaccination for their daughters as they did not have sufficient knowledge and negative attitude about the HPV vaccine.16

A study conducted in Gonder town revealed that the acceptance of HPV vaccination was significantly associated with the level of knowledge about CC, HPV vaccine, and the attitude towards HPV vaccination.5 Adequate understanding of the level of knowledge and attitude of mothers who have eligible daughters for the HPV vaccine and associated factors could be considered as a prerequisite for the effective vaccination program and the implementation of a sound and accepted primary prevention program of CC. If the attitude to the HPV vaccine is negative they do not allow taking HPV vaccine for their daughters.

Therefore, this study aimed to find out the level of knowledge and attitude towards the human papillomavirus vaccine and associated factors among mothers who have eligible daughters in Debre Markos town, Northwest Ethiopia, 2021.

Materials and Methods

Study Design, Area and Period

A community-based cross-sectional study was conducted in Debre Markos town from February to March 2021. Debre Markos is the administrative town of East Gojjam Zone and it is found in the northwest part of the country surrounded by Gozamen woreda in the North, South, and East, and Amended woreda in the West. Debre Markos is located on the main road of Addis Ababa to Bahir-Dar. It is 300 km away from Addis Ababa which is the capital city of Ethiopia and 265 km from Bahir Dar the capital city of Amhara regional state. The town has a comprehensive hospital, 3 governmental health centers, and 7 health posts. Based on the 2007 national census convoyed by the central statistical agency of Ethiopia this town has a total population of 62,497 of whom 29,921 are men and 32,576 women. There are 11 kebeles in Debre Markos.17

Population

The source population was all mothers who had eligible daughters living in Debre Markos town whereas the study population was all mothers who had eligible daughters in the selected kebeles.

Sample Size Determination

The sample size was calculated by using single population proportion formula, assuming 59.9% had positive attitude towards HPV vaccination from a study conducted in Gonder town.5 With 95% confidence interval (CI), 5% marginal error (d) and 1.5 design effect. This gives the sample size of 554. Adding 10% non-response the final sample size was 601.

n= ((zα/2)2 p (1-p)) design effect/d2

n= ((1.96)2 (0.599) (0.401)) (1.5)/ (0.05)2=554

n= 601

Sampling Procedures

A multi-stage sampling technique was applied to select the study participants from Debre Markos town total kebeles. In the study area, there are eleven kebeles. Among 11 kebeles, 5 kebeles were selected by using a simple random sampling method (lottery method), and then proportional allocation was done to each selected kebeles. Assuming the study was involving 45% of total kebeles in the town.

Finally, the household was selected with mothers who have eligible daughters by a consecutive sampling method. The first mother was selected randomly. The total population in the selected kebeles is 981 and the total sample size taken from the selected kebeles is 601. The list of mothers who have eligible daughters was taken indirectly by their daughter’s list of registration books for HPV vaccine from Debre Markos health protection center administrator. Then home to home visit was used to get mothers who fulfilled the inclusion criteria. The data collectors were visiting three times each home if the mother is absent from her home to minimize the non-response rate.

Study Variables

Dependent variable: knowledge, attitude towards HPV vaccine.

Independent variables: Socio-demographic factors and information about HPV vaccine (hearing or not).

Operational Definitions

Mothers who have eligible daughters: mothers/guardians who have young daughters aged 14 years.

Knowledge: Knowledge score was computed by giving 1 for participants who correctly answered the questions and 0 for those who did not. It was measured using 13 item knowledge questions and categorized as “Poor knowledge” (0–7 out of 13 items), and “good Knowledge” (8–13 out of 13 items).5

Attitude: attitude score was computed by giving 1 for participants who correctly answered the questions and 0 for those who did not. It was measured using 12 item attitude questions and categorized as “negative attitude” (0–6 out of 12 items), and “positive attitude” (7–12 out of 12 items).5

Data Collection Tool and Data Quality Control

A face-to-face interview-administered questionnaire was used to collect the data. Five health extension workers were the data collectors and one supervisor with BSc Degree who lives in Debre Markos town. The questionnaire consists of part one: socio-demographic, part two: source of information, part three: knowledge on HPV, and part four: attitude towards HPV vaccination adapted from different literature. The questionnaire was initially prepared in English and translated into Amharic and again back to English by professional translators to check for any inconsistencies. Finally, the Amharic version was used for the data collection. A pilot study was done 1 week before actual data collection by taking a sample of 5%31 in Kebele 4. The reliability test for the data collection tool was checked and revealed the Cronbach alpha value of 0.789, and 0.7 for knowledge and attitude respectively.

Before data collection, to ensure the quality of the data two-day training were given to data collectors and supervisors. The collected data were checked for completeness.

Data Processing and Analysis

The collected data were entered into Epi data version 3.1 and analysis was done using the SPSS version 25 statistical package. Descriptive statistics were used to describe the variable of the study. The bivariate and multivariate logistic regression models were fitted to identify the association between dependent and independent variables. All independent variables with P-value < 0.25 with knowledge, and attitude of HPV vaccine in binary logistic regression variables were transferred to multiple logistic regressions to adjust the effect of confounders and to differentiate the associated factors.

In the multivariable logistic regression model fitting, an adjusted odds ratio (AOR) with a 95% confidence interval (CI) was computed. A P-value less than 0.05 was considered to be statistically significant at 95% CI.

Ethical Consideration

Before data collection, ethical clearance and an approval letter were taken from the Ethical Review Committee of Addis Ababa University College of Health Sciences, School of Nursing and Midwifery. Then a letter was written for Debre Markos town administrator and respective Kebele managers informed about the purpose of the research undertaking. Data collection was done after written voluntary consent was taken from each study participant. This study complies with the Declaration of Helsinki.

Results

Socio-Demographic Characteristics of the Respondents

The socio-demographic characteristics of the study participants were depicted in Table 1.

Table 1 Socio-Demographic Characteristics of Mothers/Guardians Who Have Eligible Daughters in Debre Markos Town, Northwest Ethiopia, 2021 (n=601)

A total of 601 study participants with a response rate of 100% were included in this study. The mean (SD) age of the respondents was 39.4 (±8.95) years and 477 (79.4%) were married, 509 (84.7%) were orthodox Christian, 227 (37.8%) were housewife, mean monthly income of the participants were 3022.85 (±2607) Ethiopian birr. The majority of the respondents 551 (91.7%) had less than or equal to five children and 530 (88.2%) had one daughter aged 9–14 years in the household.

Source of Information

The majority of the respondents 381 (63.4%) heard about the HPV vaccine and from this for 274 (71.9%) respondents’ main source of information about the HPV vaccine was television (Figure 1).

Figure 1 The percentage distribution of sources of information about HPV vaccine among mothers/guardians who have eligible daughters in Debre Markos Town, Northwest Ethiopia, 2021.

Knowledge About the HPV Vaccine

About 315 (52.4%) of the respondents have poor knowledge about the HPV vaccine. Knowledge of respondents about HPV vaccine shows that 453 (75.4%) of parents expressed that they heard about CC, but only 258 (42.9%) of parents know CC is a disease of the genital tract, even only 179 (29.8%) of parents know that HPV can cause CC. More than half of the participants 399 (66.4%) did not know HPV is transmitted by sexual contact; 373 (62.1%) did not know the recommendation of HPV vaccine before the onset of sexual activity, and 65 (10.8%) of the parents reported that HPV vaccine is given only for women those who have multiple sexual partners (Table 2).

Table 2 Knowledge About HPV Vaccine Among Mothers/Guardians Who Have Eligible Daughters in Debre Markos Town, Northwest Ethiopia, 2021 (n=601)

Attitude Towards HPV Vaccine

The majority of the participants 465 (77.4%) had positive attitudes towards the HPV vaccine. From total study participants, 330 (54.9%) replied, they do not think their daughters are susceptible to HPV infection; 154 (25.6%) of mothers/guardians said HPV vaccine is not safe and effective; 195 (32.4%) of respondents think HPV vaccine will lead to complicated sexual activities; 272 (45.3%) of respondents think vaccinating their daughter against HPV will encourage them to start sexual activity and 203 (33.8%) of mothers/guardians believe HPV vaccine promotes risky sexual behaviors among teenagers (Table 3).

Table 3 Attitude Towards HPV Vaccine Among Mothers/Guardians Who Have Eligible Daughters in Debre Markos Town, Northwest Ethiopia, 2021 (n=601)

More than half of mothers/guardians 315 (52.4%) afraid of mild side effects of HPV vaccine for their daughter; 170 (28.3%) of respondents fear infertility from HPV vaccine for their daughter in the future, and 103 (17.1%) of respondents think only who are promiscuous would benefit from the vaccine. Table 3 shows the result of attitude towards HPV vaccine (Table 3).

Factors Associated with Knowledge About the HPV Vaccine

For bivariate logistic regression analysis, a total of thirteen variables were used and among these, eleven of the variables (maternal age, marital status, maternal educational level, maternal occupation, maternal monthly income, paternal occupation, paternal educational level, paternal monthly income, number of children in the household, hearing about the HPV vaccine and attitude) were all candidate variables for multivariable analysis. After controlling for confounders using the multivariate analysis model, maternal educational level, hearing about the HPV vaccine, and attitude towards HPV vaccine was significantly associated with knowledge about HPV vaccine (Table 4).

Table 4 Bivariable and Multivariable Analysis of Factors Associated with Knowledge About HPV Vaccination (n=601)

This study revealed that mothers who had a degree and above were about 8 times more likely to have good knowledge about HPV vaccine than mothers who cannot read and write (AOR=7.687; 95% CI=1.837–32.168; p=0.005) and also mothers who had diplomas were about 4 times more likely to have good knowledge about HPV vaccine than mothers who cannot read and write (AOR=3.540; 95% CI=1.165–10.754; P=0.026). Mothers who did not hear about the HPV vaccine before this study were about 82.8% less likely to have good knowledge about the HPV vaccine than mothers who heard about the HPV vaccine before this study (AOR=0.172; 95% CI=0.098–0.302; P=0.000). Mothers who had a positive attitude towards the HPV vaccine were about 3 times more likely to have good knowledge about the HPV vaccine than mothers who had a negative attitude towards the HPV vaccine (AOR=2.959; 95% CI=1.580–5.539; P=0.001) (Table 4).

Factors Associated with Attitude Towards HPV Vaccine

For bivariate logistic regression analysis, a total of thirteen variables were used and among these, ten of the variables (maternal age, maternal educational level, religion, maternal occupation, maternal monthly income, paternal occupation, paternal educational level, number of daughters aged 9–14, hearing about HPV vaccine and knowledge about HPV vaccine). After controlling for confounders using the multivariate analysis model, hearing about the HPV vaccine and knowledge about the HPV vaccine were significantly associated with attitudes towards the HPV vaccine (Table 5).

Table 5 Bivariable and Multivariable Analysis of Factors Associated with Attitude Towards HPV Vaccination (n=601)

This study revealed that mothers who did not hear about the HPV vaccine before this study were about 71.5% less likely to have a positive attitude towards the HPV vaccine than mothers who heard about the HPV vaccine before this study (AOR=0.285; 95% CI=0.163–0.499; P=000). Mothers who had good knowledge about the HPV vaccine were about 3 times more likely to have a positive attitude towards the HPV vaccine than mothers who had poor knowledge about the HPV vaccine (AOR=2.705; 95% CI=1.454–5.035;0.002) (Table 5).

Discussion

The study was conducted to assess knowledge and attitude towards the HPV vaccine and associated factors among mothers who have eligible daughters in Debre Markos town. The finding of this study indicated that less than half of the respondents (47.6%) had good knowledge about the HPV vaccine. This finding is consistent with the study conducted in Indonesia (44%)18 and Brazil (51.79%).19 However, this finding is higher than the studies done in Malaysia (38%)20 and Sharjah (19%).21 The discrepancy could be due to mothers those working in the medical field (health professionals) being excluded from the study conducted in Sharjah and the study conducted in Malaysia the questions were self-administer which may affect parents’ responses related to questions clarity.

In the current study, nearly two-thirds of the study participants (63.4%) heard about the HPV vaccine. This finding is lower than a study done in Brazil (75.91%)19 but higher than the studies conducted in Bangladesh (56%),22 Nigeria (36.5%),23 Arab Communities (26.1%),24 Kazakhstani (52%),25 and Lebanon (34%).26 The possible explanation for these differences might be due to the difference in the access to information since the study in Nigeria is an institutional base.

The finding of this study showed that 71.9% of the respondent’s main source of information about the HPV vaccine was television which is similar to a study done in the United Arab Emirates.21 On the contrary, the finding of this study is higher than the studies conducted in Bangladesh (30%)22 and Serbia (29.1%).27 Their main source of information is newspapers for Bangladesh and health care providers for Serbia. The reason behind this difference might be due to the difference in socio-economic and socio-demographic variables.

The finding of the current study showed that only 29.8% of parents knew that HPV can cause cervical cancer. This finding is lower than studies done in Malaysia (86.8%),20 Serbia (67.7%),27 India (67.5%),28 Indonesia (64.74%),29 and Lebanon (34%).26 This difference might be due to differences in study participants’ level of education since the study in Malaysia the lower level of education was a primary school; in Indonesia, junior high school and convenience sampling were employed, and also in India, the study population was medical students.

One-third of participants (33.6%) knew HPV is transmitted by sexual contact. This finding is similar to a study conducted in Malaysia (32.8%)20 but lower than studies conducted in Indonesia (52%),29 Serbia (64.2%),27 Brazil (82%),30 and India (97.5%).28 The possible reason might be the difference in the sample size, the study population, and the time of the study.

Nearly three-fourths of participants (73.2%) knew the presence of a vaccine against HPV infection which is similar to a study done in Serbia (67.7%).27 This finding is in disagreement with a study done in Nigeria (18.9%).23 This difference may be due to the introduction of the routine free HPV vaccination program at school in Ethiopia unlike in Nigeria which is given by cost.

In this study, 37.9% of respondents knew the recommendation of the HPV vaccine before the onset of sexual activity. This finding is similar to a study done in Serbia (43.3%).27 However, our finding is higher than studies conducted in Ghana (21.7%),31 and Indonesia (24%).29 The possible reason might be the difference in study participants. Since both studies in Ghana and Indonesia includes males and females.

Likewise, 71.4% of the respondents knew the HPV vaccine prevents cervical cancer in the future. This finding is higher than studies done in Malaysia (31.8%),20 India (55%),28 and Ghana (55.9%).31 The possible reasons might be due to the difference in sample size (ie the study done in Malaysia with a small sample size which is 280); time of the study (the study conducted in India among medical students immediately as the vaccine is introduced) and socio-demographic.

Greater than half (58.2%) of the respondents knew HPV vaccine recommended age for females which is higher than studies conducted in India on female medical students (35%),28 and Indonesia (36.99%).29 The reason for this variation may be this data was collected during the vaccine is given to daughters. So, this gives the mothers to have recent information. But other studies may face recall bias.

Greater than three-fourths of the participants (77.4%) had positive attitudes towards the HPV vaccine. This finding is found in the range of a systemic review done in southeast Asia (36.1–92.1)10 But it is higher than studies conducted in Gonder town, Ethiopia which is (59.9%),5 and India (69.07%).32 The reason for this difference could be a difference in the study period since the study in Gonder is conducted as soon as the HPV vaccine is launched in Ethiopia.

The majority of the (74.4%) respondents believe that the HPV vaccine is safe and effective which is similar to a study done in Indonesia (75%).29 On the other hand, it is higher than a study conducted in India (27%).15 The reason for this difference might be a difference of study participants since the Indian study excludes single parents from the study.

Forty- five percent of respondents believed that vaccinating their daughter against HPV encourages them to start sexual activity. This finding is higher than a study done in Saudi (20%),33 the reason for this variation might be due to the difference of study participants since the Saudi study was done on health professionals and convenience sampling was used.

In the current study, 77% of participants believed that the HPV vaccine is effective in preventing cervical cancer which is lower than a study conducted in Brazil (90.7%).30 The possible reasons might be due to the difference in socio-economic, socio-demographic, and the study conducted in Brazil was with a small sample size (ie 219 participants).

The finding of this study shows that (52.4%) of participants were afraid of the mild side effect of HPV vaccination for their daughter which is greatly higher than a study conducted in Serbia (1.3%).27 The possible cause for this difference might be the study conducted in Serbia was institutionally based and the participants were parents who have regular annual pediatric check-ups. This may give the participants information about HPV vaccine side effects.

The finding of the current study showed that maternal educational level, hearing about the HPV vaccine, and attitude of the mothers/guardians have an impact on knowledge of HPV vaccine of participants. Mothers who had a degree and above were about 8 times more likely to have good knowledge about HPV vaccine than mothers who cannot read and write (AOR=7.687; 95% CI=1.837–32.168; p=0.005) and also mothers who had diplomas were about 4 times more likely to have good knowledge about HPV vaccine than mothers who cannot read and write (AOR=3.540; 95% CI=1.165–10.754; P=0.026), which is similar to a study conducted in the United States,34 and Nigeria.23 This might also be justified that those who have higher educational levels and who heard about the HPV vaccine may know about the HPV vaccine by reading different sources.

The finding of the current study show hearing about the HPV vaccine and knowledge about the HPV vaccine was significantly associated with attitude towards the HPV vaccine. Mothers who did not hear about the HPV vaccine before this study were about 82.8% less likely to have good knowledge about the HPV vaccine than mothers who heard about the HPV vaccine before this study (AOR=0.172; 95% CI=0.098–0.302; P=0.000) which is similar to a study done in Brazil.30 Mothers who had good knowledge about the HPV vaccine were about 3 times more likely to have a positive attitude towards HPV vaccine than mothers who had poor knowledge about the HPV vaccine (AOR=2.705; 95% CI=1.454–5.035;0.002), which is similar to a study done in India.35 This justifies that knowing the HPV vaccine would bring behavioral change and also hearing about the vaccine triggers the participants to read and know more about the vaccine.

Limitations of the Study

Since this study is used a cross-sectional study design. It does not show a true cause-effect relationship between dependent and independent variables. And also the information collected quantitatively was not triangulated with the qualitative method.

Conclusions

Knowledge of mothers who have eligible daughters about the HPV vaccine was low. Maternal educational level, hearing about the HPV vaccine and attitude towards HPV vaccine were factors associated with knowledge about the HPV vaccine. Attitude towards HPV vaccine was high. Knowledge about the HPV vaccine and hearing about the HPV vaccine were factors associated with attitudes of mothers/ guardians towards the HPV vaccine.

An integrated work on behavioral change focusing on improving the knowledge about HPV vaccine; continuous health education at different places like schools, community level and through media to disseminate information regarding the importance of HPV vaccine the most effective strategies that should be considered by Debre Markos town health office with other non-governmental organizations working on health and health-related issues.

Data Sharing Statement

All relevant data are within the paper. The datasets used and/or analyzed during the current study are available on reasonable request from the corresponding author.

Acknowledgment

We acknowledged Addis Ababa University for sponsoring this research. We also thank the Debre Markos town health office for permitting us to collect data. Finally, my deepest gratitude goes to data collectors and supervisors for their active participation and cooperation in the current study. This work is a master thesis done at Addis Ababa University. (http://etd.aau.edu.et/bitstream/handle/123456789/28717/Melkam%20Tesfaye.pdf?isAllowed=y&sequence=1).

Author Contributions

All authors of this study made a significant contribution to the conception, study design, execution, acquisition of data, analysis, and interpretation of the reported work, or in all these areas; took part in drafting, revising, or critically reviewing the article; gave final approval of the version to be published and agree to be accountable for all aspects of the work.

Funding

Addis Ababa University covers some financial issues.

Disclosure

The authors declare that they have no competing interests in this work.

References

1. Gebremariam T. Human papillomavirus-related cervical cancer and anticipated vaccination challenges in Ethiopia. Int J Health Sci. 2016;10(1):137. doi:10.12816/0031220

2. Netfa F, Tashani M, Booy R, King C, Rashid H, Skinner SR. Knowledge, attitudes and perceptions of immigrant parents towards Human Papillomavirus (HPV) vaccination: a systematic review. Trop Med Infect Dis. 2020;5(2):58. doi:10.3390/tropicalmed5020058

3. Jalani FFM, Rani MDM, Isahak I, Aris MSM, Roslan N. Knowledge, attitude, and practice of human papillomavirus (HPV) vaccination among secondary school students in rural areas of Negeri Sembilan, Malaysia. Int J Collab Res Intern Med Public Health. 2016;8(6):56.

4. Heena H, Durrani S, AlFayyad I, et al. Knowledge, attitudes, and practices towards cervical cancer and screening amongst female healthcare professionals: a cross-sectional study. J Oncol. 2019;2019. doi:10.1155/2019/5423130

5. Alene T, Atnafu A, Mekonnen ZA, Minyihun A. Acceptance of Human Papillomavirus vaccination and associated factors among parents of daughters in Gondar Town, Northwest Ethiopia. Cancer Manag Res. 2020;12:8519. doi:10.2147/CMAR.S275038

6. Bisi-Onyemaechi AI, Chikani UN, Nduagubam O. Reducing the incidence of cervical cancer: knowledge and attitudes of caregivers in Nigerian city to human papillomavirus vaccination. Infect Agent Cancer. 2018;13(1):29. doi:10.1186/s13027-018-0202-9

7. Wollancho W, Amdissa D, Bamboo S, Wasihun Y, Tareke KG, Gizaw AT. Determining behavioral intention and its predictors towards cervical cancer screening among women in Gomma district, Jimma, Ethiopia: application of the theory of planned behavior. PLoS One. 2020;15(11):e0238472. doi:10.1371/journal.pone.0238472

8. Ruddies F, Gizaw M, Teka B, et al. Cervical cancer screening in rural Ethiopia: a cross-sectional knowledge, attitude and practice study. BMC Cancer. 2020;20(1):1–10. doi:10.1186/s12885-020-07060-4

9. Kasim J, Kalu A, Kamara B, Alema HB. Cervical cancer screening service utilization and associated factors among women in the Shabadino District, Southern Ethiopia. J Cancer Epidemiol. 2020;2020. DOI:10.1155/2020/6398394

10. Kristina SA, Permitasari NPAL. Knowledge, attitudes, and barriers towards human papillomavirus (HPV) vaccination in developing economies countries of South-East Asia Region: a systematic review. Syst Rev Pharm. 2019;10(1):81–86. doi:10.5530/srp.2019.1.13

11. World Health Organization. Ethiopia launches Human Papillomavirus Vaccine for 14-year-old girls; 2018 [cited June 2, 2022]. Available from: https://www.afro.who.int/news/ethiopia-launches-human-papillomavirus-vaccine-14-year-old-girls. Accessed February 25, 2022.

12. Megersa BS, Bussmann H, Bärnighausen T, Muche AA, Alemu K, Deckert A. Community cervical cancer screening: barriers to successful home-based HPV self-sampling in Dabat district, North Gondar, Ethiopia. A qualitative study. PLoS One. 2020;15(12):e0243036. doi:10.1371/journal.pone.0243036

13. Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination—review of current perspectives. J Oncol. 2019;2019. doi:10.1155/2019/3257939

14. Grandahl M, Chun Paek S, Grisurapong S, Sherer P, Tyden T, Lundberg P. Parents’ knowledge, beliefs, and acceptance of the HPV vaccination about their socio-demographics and religious beliefs: a cross-sectional study in Thailand. PLoS One. 2018;13(2):e0193054. doi:10.1371/journal.pone.0193054

15. Roy S, Dubey A, Saini D, et al. Knowledge, attitude and practice regarding HPV vaccine among parents and caregivers of female child attending pediatric OPD: intervention for primary prevention. Ind J Soc Prev Rehab Oncol. 2017;1(2):34–40.

16. Kose D, Erkorkmaz U, Cinar N, Altinkaynak S. Mothers’ knowledge and attitudes about HPV vaccination to prevent cervical cancers. Asian Pac J Cancer Prev. 2014;15(17):7263–7266. doi:10.7314/APJCP.2014.15.17.7263

17. Aschale TM. Assessment of schools spatial distribution and identifying suitable areas by using GIS technology: in case of Debre Markos Town North Western Ethiopia . J Resour Dev Manag. 2017;35:114.

18. Endarti D, Satibi SAK, Farida MA, Rahmawanti Y, Andriani T. Knowledge, perception, and acceptance of HPV vaccination and screening for cervical cancer among women in Yogyakarta Province, Indonesia. Asian Pac J Cancer Prev. 2018;19(4):1105. doi:10.22034/APJCP.2018.19.4.1105

19. Kops NL, Hohenberger GF, Bessel M, et al. Knowledge about HPV and vaccination among young adult men and women: results of a national survey. Papillomavirus Res. 2019;7:123–128. doi:10.1016/j.pvr.2019.03.003

20. Sopian MM, Shaaban J, Yusoff SSM, Mohamad WMZW. Knowledge, decision-making and acceptance of Human Papilloma Virus vaccination among parents of primary school students in Kota Bharu, Kelantan, Malaysia. Asian Pac J Cancer Prev. 2018;19(6):1509. doi:10.22034/APJCP.2018.19.6.1509

21. Saqer A, Ghazal S, Barqawi H, Babi JA, AlKhafaji R, Elmekresh MM. Knowledge and awareness about cervical cancer vaccine (HPV) among parents in Sharjah. Asian Pac J Cancer Prev. 2017;18(5):1237. doi:10.22034/APJCP.2017.18.5.1237

22. Bhuiyan A, Sultana F, Islam JY, Chowdhury MAK, Nahar Q. Knowledge and acceptance of Human Papillomavirus vaccine for cervical cancer prevention among urban professional women in Bangladesh: a mixed-method study. Biores Open Access. 2018;7(1):63–72. doi:10.1089/biores.2018.0007

23. Okunade KS, Sunmonu O, Osanyin GE, Oluwole AA. Knowledge and acceptability of human papillomavirus vaccination among women attending the gynecological outpatient clinics of a university teaching hospital in Lagos, Nigeria. J Trop Med. 2017;2017:8586459.

24. Alsous MM, Ali AA, Al-Azzam SI, et al. Knowledge and awareness about human papillomavirus infection and its vaccination among women in Arab communities. Sci Rep. 2021;11(1):786. doi:10.1038/s41598-020-80834-9

25. Issa T, Babi A, Issanov A, et al. Knowledge and awareness of human papillomavirus infection and human papillomavirus vaccine among Kazakhstani women attending gynecological clinics. PLoS One. 2021;16(12):e0261203. doi:10.1371/journal.pone.0261203

26. Abou El-Ola MJ, Rajab MA, Abdallah DI, et al. Low rate of human papillomavirus vaccination among schoolgirls in Lebanon: barriers to vaccination with a focus on mothers’ knowledge about available vaccines. Ther Clin Risk Manag. 2018;14:617–626. doi:10.2147/TCRM.S152737

27. Marić G, Birčanin Đ, Kisić V, et al. Parental perspective on human papillomavirus (HPV) vaccination in Serbia: knowledge, attitudes, and practice. Sex Reprod Healthc. 2018;16:192–198. doi:10.1016/j.srhc.2018.04.010

28. Choudhary G, Jodha B, Sharma C, et al. Knowledge of HPV and attitude towards HPV vaccination among medical students of Jodhpur, Rajasthan. Int J Med Health Res. 2018;4(3):94–97.

29. Kristina S, Lienaningrum AS, Wulandari GP. Beliefs and acceptance of the Human papillomavirus (HPV) vaccine among parents in an urban community in Yogyakarta. Int J Pharm Res. 2020;12:662–667.

30. Gattegno MV, Vertamatti MA, Bednarczyk RA, Evans DP. A cross-sectional survey of parental attitudes towards Human papillomavirus vaccination exclusion categories in Brazil. BMC Int Health Hum Rights. 2019;19(1):6. doi:10.1186/s12914-019-0195-5

31. Drokow EK, Zi L, Han Q, et al. Awareness of cervical cancer and attitude toward human papillomavirus and its vaccine among Ghanaians. Front Oncol. 2020;10. doi:10.3389/fonc.2020.01651

32. Radhika M, Sadiqunissa S, Ahmed M. Awareness and knowledge of human papillomavirus (HPV) vaccine in prevention of cervical cancer among medical students. Int J Reprod Contracept Obstet Gynecol. 2018;7(12):5026. doi:10.18203/2320-1770.ijrcog20184960

33. Almazrou S, Saddik B, Jradi H. Knowledge, attitudes, and practices of Saudi physicians regarding cervical cancer and the human papillomavirus vaccine. J Infect Public Health. 2019;13(4):584–590. doi:10.1016/j.jiph.2019.09.002

34. Mohammed KA, Vivian E, Loux TM, Arnold LD. Peer-reviewed: factors associated with parents’ intent to vaccinate adolescents for human papillomavirus: findings from the 2014 National Immunization Survey–Teen. Prev Chronic Dis. 2017;14. doi:10.5888/pcd14.160314

35. Degarege A, Krupp K, Srinivas V, et al. Determinants of attitudes and beliefs toward human papillomavirus infection, cervical cancer, and human papillomavirus vaccine among parents of adolescent girls in Mysore, India. J Obstet Gynaecol Res. 2018;44(11):2091–2100. doi:10.1111/jog.13765

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.